{"id":375823,"date":"2010-03-01T10:42:11","date_gmt":"2010-03-01T15:42:11","guid":{"rendered":"tag:www.hepatitis-central.com,2010:\/mt\/\/1.781"},"modified":"2010-03-01T10:43:51","modified_gmt":"2010-03-01T15:43:51","slug":"hcv-treatment-induced-anemia-predicted-by-genetics","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/375823","title":{"rendered":"HCV Treatment-Induced Anemia Predicted by Genetics"},"content":{"rendered":"<p>Thanks to research from Duke University&#8217;s Institute for Genome Sciences &#038; Policy, scientists have confirmed that some individuals have genetic protection against ribavirin-induced anemia. Since ribavirin is part of the standard Hepatitis C treatment protocol, this discovery will better enable physicians to foretell who can best withstand Hepatitis C therapy.<\/p>\n<p>Enzyme Deficiency Protects Hepatitis C Patients from Treatment-Related Anemia<\/p>\n<p>ScienceDaily (Feb. 24, 2010) &#8212; Many people who undergo treatment for hepatitis C develop hemolytic anemia, a disorder that destroys red blood cells. In some cases, it is so severe they have to reduce their medication or stop therapy altogether. But now, scientists in Duke University&#8217;s Institute for Genome Sciences &#038; Policy (IGSP) have discovered two genetic alterations linked to a benign enzyme condition that keep some patients anemia-free.<\/p>\n<p>Continue reading this entire article:<br \/>\n<a href=\"http:\/\/www.sciencedaily.com\/releases\/2010\/02\/100221143232.htm\">http:\/\/www.sciencedaily.com\/releases\/2010\/02\/100221143232.htm<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Thanks to research from Duke University&#8217;s Institute for Genome Sciences &#038; Policy, scientists have confirmed that some individuals have genetic protection against ribavirin-induced anemia. Since ribavirin is part of the standard Hepatitis C treatment protocol, this discovery will better enable physicians to foretell who can best withstand Hepatitis C therapy. Enzyme Deficiency Protects Hepatitis C [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-375823","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/375823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=375823"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/375823\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=375823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=375823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=375823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}